Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04158154Not ApplicableCompleted

Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design

Role: collaborator

NCT05664256Not ApplicableRecruiting

Evaluation of a Healthy Food Procurement Policy at Municipality-level in Nepal

Role: collaborator

NCT04992039Not ApplicableCompleted

HEARTS Package Evaluation Trial in Bangladesh

Role: collaborator

NCT05155436Phase 4Completed

Occurrence of Dyskalemia With Treatment for Hypertension

Role: collaborator

NCT05549388Not ApplicableCompleted

Effect of Front-of-Pack Labels in Ethiopia

Role: collaborator

All 5 trials loaded